Clinical trials
Phase 4 Infertility trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Withdrawn | 4 |
| Terminated | 4 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ferring Pharmaceuticals | 4 |
| Weill Medical College of Cornell University | 4 |
| Center for Human Reproduction | 3 |
| University of California, San Francisco | 3 |
| Brigham and Women's Hospital | 2 |
| Rachel Mejia | 2 |
| University Reproductive Associates | 2 |
| Wake Forest University Health Sciences | 2 |
| Colorado Center for Reproductive Medicine | 1 |
| Fertility Center of Las Vegas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infertility | 34 |
| Polycystic Ovary Syndrome | 3 |
| Abortion, Habitual | 1 |
| Abortion, Spontaneous | 1 |
| Aneuploidy | 1 |
| Breast Neoplasms | 1 |
| Chromosome Aberrations | 1 |
| Endometriosis | 1 |
| Hyperprolactinemia | 1 |
| Postoperative Pain | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.